English
español
Please use this identifier to cite or link to this item:
http://hdl.handle.net/10261/209458
Share/Impact:
Statistics |
![]() ![]() ![]() |
|
|
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |||
|
Title: | Iron Oxide Nanoparticles: An Alternative for Positive Contrast in Magnetic Resonance Imaging |
Authors: | Fernández-Barahona, Irene; Muñoz-Hernando, María; Ruiz-Cabello, Jesús; Herranz, Fernando ![]() |
Keywords: | Iron oxide nanoparticles Magnetic resonance imaging Positive contrast agents |
Issue Date: | 10-Apr-2020 |
Publisher: | Multidisciplinary Digital Publishing Institute |
Citation: | Inorganics 8(4): 28 (2020) |
Abstract: | Iron oxide nanoparticles have been extensively utilised as negative (T2) contrast agents in magnetic resonance imaging. In the past few years, researchers have also exploited their application as positive (T1) contrast agents to overcome the limitation of traditional Gd3+ contrast agents. To provide T1 contrast, these particles must present certain physicochemical properties with control over the size, morphology and surface of the particles. In this review, we summarise the reported T1 iron oxide nanoparticles and critically revise their properties, synthetic protocols and application, not only in MRI but also in multimodal imaging. In addition, we briefly summarise the most important nanoparticulate Gd and Mn agents to evaluate whether T1 iron oxide nanoparticles can reach Gd/Mn contrast capabilities |
Description: | © 2020 by the authors. |
Publisher version (URL): | https://doi.org/10.3390/inorganics8040028 |
URI: | http://hdl.handle.net/10261/209458 |
DOI: | 10.3390/inorganics8040028 |
E-ISSN: | 2304-6740 |
Appears in Collections: | (IQM) Artículos |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
inorganics-08-00028.pdf | 2,45 MB | Adobe PDF | ![]() View/Open |
Show full item record
Review this work
Review this work
Related articles:
WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.